Profil
John J.
Whitehead is a Director of Digene Corp.
and the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology and a Director Emeritus of i-STAT Corp.
He has been a Partner of Whitehead Partners since 1993.
Prior to joining Digene, Mr. Whitehead was Chief Executive Officer of TDS Healthcare Systems Corp.
from 1986 to 1993.
Aktiva positioner av John J. Whitehead
| Företag | Position | Start |
|---|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Direktör/Styrelseledamot | - |
Tidigare kända positioner av John J. Whitehead
| Företag | Position | Slut |
|---|---|---|
i-STAT Corp.
i-STAT Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical diagnostic products | Direktör/Styrelseledamot | 2008-11-13 |
TDS Healthcare Systems Corp
TDS Healthcare Systems Corp Packaged SoftwareTechnology Services Business oriented computer software | President | 1993-01-01 |
Digene Corp.
Digene Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and markets DNA and RNA tests | Direktör/Styrelseledamot | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
i-STAT Corp.
i-STAT Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical diagnostic products | Health Technology |
Digene Corp.
Digene Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and markets DNA and RNA tests | Electronic Technology |
TDS Healthcare Systems Corp
TDS Healthcare Systems Corp Packaged SoftwareTechnology Services Business oriented computer software | Technology Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
















